Japan Medical Dynamic Marketing, Inc. (JP:7600)
:7600
Want to see JP:7600 full AI Analyst Report?
Top Page
Japan Medical Dynamic Marketing, Inc.
(7600)
Select Model
Select Model
Rating:62Neutral
Price Target:
¥533.00
▲(9.45% Upside)
Action:ReiteratedDate:04/29/26
The score is primarily driven by mixed financial performance: stable growth and a solid, low-leverage balance sheet are offset by negative 2025 profitability and free cash flow. Technicals add a modest drag due to the price trading below key moving averages, while valuation is a relative support with a moderate P/E and a ~2.7% dividend yield.
Positive Factors
Balance Sheet Strength
A strong equity base and conservative leverage provide durable financial flexibility: it lowers refinancing risk, supports continued R&D and product investment in medical devices, and gives the company capacity to absorb cyclical shocks over the next 2–6 months without forcing distress-driven asset sales.
Negative Factors
Negative Net Profit Margin (2025)
A shift to negative net margins erodes retained earnings and reduces internal funding for growth or R&D. If margins remain negative, the company may need recurring external financing, hampering strategic flexibility and increasing long-term vulnerability in a competitive medical-device market.
Read all positive and negative factors
Positive Factors
Negative Factors
Balance Sheet Strength
A strong equity base and conservative leverage provide durable financial flexibility: it lowers refinancing risk, supports continued R&D and product investment in medical devices, and gives the company capacity to absorb cyclical shocks over the next 2–6 months without forcing distress-driven asset sales.
Read all positive factors
Japan Medical Dynamic Marketing, Inc. (7600) vs. iShares MSCI Japan ETF (EWJ)
Market Cap
¥13.25B
Dividend Yield3.12%
Average Volume (3M)89.74K
Price to Earnings (P/E)14.8
Beta (1Y)0.52
Revenue Growth-0.24%
EPS Growth-174.33%
CountryJP
Employees511
SectorHealthcare
Sector Strength45
IndustryMedical - Devices
Share Statistics
EPS (TTM)-50.93
Shares Outstanding26,475,880
10 Day Avg. Volume96,020
30 Day Avg. Volume89,743
Financial Highlights & Ratios
PEG Ratio0.24
Price to Book (P/B)0.61
Price to Sales (P/S)0.60
P/FCF Ratio-29.78
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Japan Medical Dynamic Marketing, Inc. Business Overview & Revenue Model
Company Description
Japan Medical Dynamic Marketing, INC. develops, manufactures, imports, and sells medical devices in Japan and the United States. The company provides trauma devices, including nails, screws, plates, and other products surgically implanted in the f...
How the Company Makes Money
null...
Japan Medical Dynamic Marketing, Inc. Financial Statement Overview
Summary
Income Statement
65
Positive
Balance Sheet
72
Positive
Cash Flow
60
Neutral
| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 24.98B | 25.11B | 23.18B | 21.31B | 19.19B | 16.74B |
| Gross Profit | 14.46B | 15.65B | 14.76B | 13.99B | 12.99B | 11.42B |
| EBITDA | 1.03B | 1.40B | 3.27B | 3.35B | 4.21B | 3.47B |
| Net Income | -669.47M | -461.80M | 1.27B | 1.42B | 2.14B | 1.66B |
Balance Sheet | ||||||
| Total Assets | 32.22B | 33.83B | 31.49B | 29.43B | 27.34B | 25.19B |
| Cash, Cash Equivalents and Short-Term Investments | 2.35B | 3.18B | 2.32B | 2.80B | 2.59B | 2.47B |
| Total Debt | 4.31B | 3.29B | 1.49B | 1.87B | 1.85B | 3.09B |
| Total Liabilities | 8.25B | 9.09B | 5.88B | 6.14B | 5.85B | 6.48B |
| Stockholders Equity | 23.96B | 24.68B | 25.51B | 23.16B | 21.39B | 18.63B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -504.10M | 302.45M | 870.67M | 1.53B | 1.23B |
| Operating Cash Flow | 0.00 | 1.05B | 2.10B | 2.19B | 3.11B | 2.60B |
| Investing Cash Flow | 0.00 | -1.67B | -1.80B | -1.48B | -1.75B | -1.35B |
| Financing Cash Flow | 0.00 | 1.49B | -840.71M | -514.78M | -1.29B | -1.31B |
Japan Medical Dynamic Marketing, Inc. Technical Analysis
Positive
487.00
Price Trends
552.16
Positive
512.15
Positive
511.63
Positive
Market Momentum
1.74
Negative
50.85
Neutral
58.59
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:7600, the sentiment is Positive. The current price of 487 is below the 20-day moving average (MA) of 552.64, below the 50-day MA of 552.16, and below the 200-day MA of 511.63, indicating a bullish trend. The MACD of 1.74 indicates Negative momentum. The RSI at 50.85 is Neutral, neither overbought nor oversold. The STOCH value of 58.59 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:7600.
Japan Medical Dynamic Marketing, Inc. Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥19.49B | 15.12 | ― | 3.02% | 3.79% | -7.91% | |
68 Neutral | ¥102.37B | 26.70 | ― | 2.31% | 2.68% | 84.62% | |
65 Neutral | ¥243.90B | 36.37 | ― | 1.92% | 2.97% | -26.69% | |
62 Neutral | ¥13.25B | 14.76 | ― | 3.12% | -0.24% | -174.33% | |
56 Neutral | ¥63.55B | 87.82 | -0.46% | ― | -4.55% | 99.67% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
51 Neutral | ¥128.24B | 28.05 | 2.42% | 3.73% | -0.05% | -40.08% |
* Healthcare Sector Average
JP:7600
Japan Medical Dynamic Marketing, Inc.
503.00
-38.62
-7.13%
JP:7779
CYBERDYNE
301.00
127.00
72.99%
JP:6523
PHC Holdings Corp.
1,012.00
87.49
9.46%
JP:4549
Eiken Chemical Co., Ltd.
3,105.00
936.60
43.19%
JP:6678
Techno Medica Co., Ltd.
2,287.00
527.44
29.98%
JP:6849
Nihon Kohden Corporation
1,461.00
-229.45
-13.57%
Japan Medical Dynamic Marketing, Inc. Corporate Events
Japan Medical Dynamic Marketing Reshapes Auditor Lineup to Bolster Governance
Mar 27, 2026
Japan Medical Dynamic Marketing, Inc. announced a change in its audit structure following the resignation of full-time auditor Katsuhiko Seshita, effective March 31, 2026, due to personal reasons. As of April 1, 2026, Yoshiaki Jitto will become a ...
Japan Medical Dynamic Marketing Overhauls Governance and Executive Lineup
Mar 27, 2026
Japan Medical Dynamic Marketing, Inc. will shift its governance structure from a company with a Board of Company Auditors to a company with an Audit and Supervisory Committee, pending shareholder approval at its June 19, 2026 annual meeting. The b...
Japan Medical Dynamic Marketing Plans Governance Shift and Electronic Disclosure Move
Mar 27, 2026
Japan Medical Dynamic Marketing will ask shareholders at its June 19, 2026 annual meeting to approve a shift from a traditional company auditor structure to a Company with an Audit and Supervisory Committee and to move its public notices to an ele...
Japan Medical Dynamic Marketing Profit Slumps but Dividend Raised Despite Weak Outlook
Jan 30, 2026
Japan Medical Dynamic Marketing reported a 2.9% year-on-year decline in net sales to ¥17.9 billion for the nine months ended December 31, 2025, with operating profit dropping 57.9% to ¥518 million and profit attributable to owners of par...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.